---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-003199"
form_type: "8-K"
ticker: "ZSQR"
cik: "0001759186"
company_name: "Z Squared Inc."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:13:07.187567+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Coeptis completes reverse merger with Z Squared; shares to trade as ZSQR April 27

## Summary
- Coeptis Therapeutics completes business combination with computing infrastructure firm Z Squared Inc.
- Combined entity renamed Z Squared Inc.; shares to trade on Nasdaq Global Market under ZSQR starting April 27, 2026.
- Prior to close, Coeptis distributed its biopharmaceutical business to its stockholders via pro rata distribution.
- Post-merger: ~51.5M shares outstanding; former Z Squared stockholders own ~85%, legacy Coeptis holders own ~15%.
- Z Squared COO cites vertically integrated platform across three states with dynamic power management and hardware lifecycle program.

## SEC filing metadata
- accession: 0001683168-26-003199
- form_type: 8-K
- ticker: ZSQR
- cik: 0001759186
- company_name: Z Squared Inc.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/0001683168-26-003199-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/coeptis_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-003199
- JSON: https://secwatch.observer/filing/0001683168-26-003199.json
- Plain text: https://secwatch.observer/filing/0001683168-26-003199.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.